Vesugen

Vesugen is a Khavinson tripeptide bioregulator (Lys-Glu-Asp / KED) originally isolated from vascular-wall extracts in Russian gerontology research. It has been studied in animal and cell-culture models for endothelial function, vascular-tissue ageing parameters, and gene-expression effects in vessel-derived cells, alongside the cardiac peptide Cardiogen and the bronchial peptide Bronchogen. Sold by research-peptide vendors at 5–20 mg vial sizes for laboratory work; not approved by FDA, MHRA, Health Canada, or TGA for human use. Research-use only — Pepticker does not provide medical advice and this entry summarises published preclinical research, not a dosing protocol.

Also known as: KED, Vascular bioregulator